Oxford Instruments plc is a provider of high technology products and services to industry and scientific research communities. The Company's segments include Materials & Characterisation, Research & Discovery, and Services & Healthcare. Its Materials & Characterisation segment is focused on applied research and development and commercial customers, enabling the fabrication and characterization of materials and devices down to the atomic scale.
Its Research & Discovery segment provides advanced solutions that create environments and enable measurements down to the molecular and atomic level, which are used in fundamental research. Its Service & Healthcare segment provides customer service and support for its products and the service of third-party healthcare imaging systems.
Its products include Atomic Force Microscopy, Electron Microscopy, Deposition Tools, Etch Tools, Low Temperature Systems and others. It offers a scientific camera. It also develops nanoindentation instruments..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 69.0K |
| Three Month Average Volume | 2.3M |
| High Low | |
| Fifty-Two Week High | 27.65 GBX |
| Fifty-Two Week Low | 16.34 GBX |
| Fifty-Two Week High Date | 11 Jun 2024 |
| Fifty-Two Week Low Date | 26 Oct 2023 |
| Price and Volume | |
| Current Price | 22.85 GBX |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -3.52% |
| Thirteen Week Relative Price Change | -7.76% |
| Twenty-Six Week Relative Price Change | -4.64% |
| Fifty-Two Week Relative Price Change | -7.68% |
| Year-to-Date Relative Price Change | -7.75% |
| Price Change | |
| One Day Price Change | -0.44% |
| Thirteen Week Price Change | -6.73% |
| Twenty-Six Week Price Change | 4.34% |
| Five Day Price Change | 1.11% |
| Fifty-Two Week Price Change | 3.63% |
| Year-to-Date Price Change | -0.44% |
| Month-to-Date Price Change | -0.44% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 6.31456 GBX |
| Book Value Per Share (Most Recent Quarter) | 6.31456 GBX |
| Tangible Book Value Per Share (Last Fiscal Year) | 3.93343 GBX |
| Tangible Book Value Per Share (Most Recent Quarter) | 3.93343 GBX |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 1.55554 GBX |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 8.0273 GBX |
| Revenue Per Share (Trailing Twelve Months) | 8.08538 GBX |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 0.208 GBX |
| Dividend Per Share (Trailing Twelve Months) | 0.208 GBX |
| Dividend Per Share (5 Year) | 0.1508 GBX |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 0.86519 GBX |
| Excluding Extraordinary Items (Trailing Twelve Months) | 0.87211 GBX |
| Normalized (Last Fiscal Year) | 0.89761 GBX |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 0.87716 GBX |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 0.87711 GBX |
| Including Extraordinary Items (Last Fiscal Year) | 0.86519 GBX |
| Including Extraordinary Items (Trailing Twelve Months) | 0.87211 GBX |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 1.68872 GBX |
| Cash Per Share (Most Recent Quarter) | 1.68872 GBX |
| Cash Flow Per Share (Last Fiscal Year) | 1.20819 GBX |
| Cash Flow Per Share (Trailing Twelve Months) | 1.22209 GBX |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.05672 GBX |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 7 |
| Cash Flow Revenue (Trailing Twelve Months) | 1 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 15.16% |
| Pretax Margin (Last Fiscal Year) | 15.16% |
| Pretax Margin (5 Year) | 14.77% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 51.53% |
| Gross Margin (Trailing Twelve Months) | 51.53% |
| Gross Margin (5 Year) | 51.30% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 14.52% |
| Operating Margin (Trailing Twelve Months) | 14.52% |
| Operating Margin (5 Year) | 14.67% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 10.78% |
| Net Profit Margin (Trailing Twelve Months) | 10.78% |
| Net Profit Margin (5 Year) | 11.56% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 12.37% |
| Tangible Book Value (5 Year) | 35.59% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -34.17% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 6.76% |
| Revenue Growth (3 Year) | 8.42% |
| Revenue Change (Trailing Twelve Months) | 5.78% |
| Revenue Per Share Growth | 8.08% |
| Revenue Growth (5 Year) | 13.88% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 23.10% |
| Total Debt (5 Year) | 4.80% |
| Dividends | |
| Dividend Growth (3 Year) | 6.96% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -24.42% |
| EPS Change (Trailing Twelve Months) | -13.12% |
| EPS Growth (3 Year) | 12.42% |
| EPS Growth (5 Year) | 6.34% |
| EBITDA | |
| EBITDA (5 Year) | 6.04% |
| EBITDA (5 Year Interim) | 8.39% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | 4.01% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 6 |
| Price to Tangible Book (Most Recent Quarter) | 6 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 401 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 401 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -50,400,000 |
| Net Debt (Last Fiscal Year) | -50,400,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 3 |
| Price to Sales (Trailing Twelve Months) | 3 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 26 |
| PE Normalized (Last Fiscal Year) | 25 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 24 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 32 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 21 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 26 |
| Dividends | |
| Dividend Yield (5 Year) | 0.76% |
| Dividend Yield | 0.91% |
| Current Dividend Yield | 0.91% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 4 |
| Price to Book (Most Recent Quarter) | 4 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 8 |
| Long Term Debt to Equity (Most Recent Quarter) | 8 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 23.76% |
| Payout Ratio (Trailing Twelve Months) | 23.74% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 40 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 40 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 3.3M |
| Free Cash Flow (Trailing Twelve Months) | 3.3M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 13 |
| Total Debt to Equity (Most Recent Quarter) | 13 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 8.61% |
| Return on Assets (Trailing Twelve Months) | 8.61% |
| Return on Assets (5 Year) | 8.88% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 14.29% |
| Return on Equity (Trailing Twelve Months) | 14.29% |
| Return on Equity (5 Year) | 15.16% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 12.88% |
| Return on Investment (Trailing Twelve Months) | 12.88% |
| Return on Investment (5 Year) | 13.83% |